skip to main content

Analyzing CBD Products for Pharmacologically Active Substances to Protect Consumers

Thomas, Lillie

VCU Scholars Compass 2024

Texto completo disponível

Citações Citado por
  • Título:
    Analyzing CBD Products for Pharmacologically Active Substances to Protect Consumers
  • Autor: Thomas, Lillie
  • Assuntos: CBD ; first responders ; Forensic Science and Technology ; product regulation
  • Notas: Master of Science in Forensic Science Directed Research Projects
    https://scholarscompass.vcu.edu/frsc_projects/104
    https://scholarscompass.vcu.edu/context/frsc_projects/article/1105/viewcontent/Thomas_Lillie_thesis.pdf
  • Descrição: There is an ever-increasing market for cannabidiol (CBD). This natural cannabinoid is used to help with pain, insomnia, and anxiety, among other things. The CBD market continues to grow and is, thus far, operating without many regulations. The companies creating these products have been advertising them as dietary supplements for easier guidelines. Minimum guidelines mean they are able to make false medical and advertising claims and inaccurate concentration labeling without repercussions. Some companies are even advertising ‘zero THC’ products to first responders, military personnel, and teachers who usually have a zero-THC tolerance policy. When there are false claims of zero THC in products and responders use them, they could test positive for THC. In this study, 14 CBD products were purchased from online stores and qualitatively and quantitatively analyzed to determine their ingredients and the concentration of cannabinoids present. After analysis, it was discovered that none of the advertised concentrations of cannabinoids were correct, with most claiming a higher concentration than was present.
  • Editor: VCU Scholars Compass
  • Data de criação/publicação: 2024
  • Idioma: Inglês

Buscando em bases de dados remotas. Favor aguardar.